CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 114 filers reported holding CUREVAC N V in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,374,892 | -75.6% | 201,302 | -62.8% | 0.00% | -100.0% |
| Q2 2023 | $5,632,344 | +251.0% | 540,532 | +134.8% | 0.00% | – |
| Q1 2023 | $1,604,856 | -20.9% | 230,252 | -31.6% | 0.00% | – |
| Q4 2022 | $2,029,733 | -19.4% | 336,606 | +5.4% | 0.00% | – |
| Q3 2022 | $2,517,000 | -43.1% | 319,295 | -1.8% | 0.00% | -100.0% |
| Q2 2022 | $4,425,000 | +33.4% | 325,153 | +92.2% | 0.00% | – |
| Q1 2022 | $3,317,000 | +5.5% | 169,157 | +84.6% | 0.00% | – |
| Q4 2021 | $3,145,000 | -15.7% | 91,626 | +34.1% | 0.00% | -100.0% |
| Q3 2021 | $3,732,000 | +4.5% | 68,346 | +40.6% | 0.00% | – |
| Q2 2021 | $3,572,000 | -27.1% | 48,603 | -9.3% | 0.00% | -100.0% |
| Q1 2021 | $4,903,000 | +255.8% | 53,599 | +215.4% | 0.00% | – |
| Q4 2020 | $1,378,000 | +201.5% | 16,995 | +73.2% | 0.00% | – |
| Q3 2020 | $457,000 | – | 9,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $16,942,326 | 13.48% |
| RA Capital Management | 12,245,955 | $127,602,851 | 2.41% |
| Avidity Partners Management LP | 4,300,000 | $44,806,000 | 1.56% |
| Camber Capital Management LP | 1,462,500 | $15,239 | 0.50% |
| Eversept Partners, LP | 357,342 | $3,723,504 | 0.31% |
| Ghisallo Capital Management LLC | 100,000 | $1,042,000 | 0.12% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 226,134 | $2,356,316 | 0.08% |
| Green Alpha Advisors, LLC | 11,492 | $119,747 | 0.08% |
| Alyeska Investment Group, L.P. | 899,423 | $9,371,988 | 0.07% |
| Virtus ETF Advisers LLC | 10,692 | $111,411 | 0.07% |